SILVER SPRING, Md. (Jan. 27, 2023) – NMRC research scientists with Naval Medical Research Center’s (NMRC) Deployment Associated Infections Division, work on Campylobacter jejuni vaccine research. Phase 1 testing of the Campylobacter vaccine is currently underway at Cincinnati Children's Hospital Medical Center. Campylobacter is one of the most common causes of diarrheal illness in the and abroad, and can impact the readiness of deployed or traveling service members. NMRC is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote
SILVER SPRING, Md. (Jan. 27, 2023) – NMRC research scientists with Naval Medical Research Center’s (NMRC) Deployment Associated Infections Division, work on Campylobacter jejuni vaccine research. Phase 1 testing of the Campylobacter vaccine is currently underway at Cincinnati Children's Hospital Medical Center. Campylobacter is one of the most common causes of diarrheal illness in the and abroad, and can impact the readiness of deployed or traveling service members. NMRC is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of the Navy, Marine Corps, and joint warfighters, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, medical modeling, simulation, operational mission support, epidemiology, and behavioral sciences.
Size: 3402px × 2268px
Photo credit: © Operation 2023 / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: center, medical, navy, research
